Ming Cheng Chang

Chief Executive Officer presso EXCELSIOR MEDICAL CO., LTD.

Consumer Services

Distribution Services

Health Technology

Profilo

Ming Cheng Chang is currently a Director at Arich Enterprise Co., Ltd., RTS Excelsior Co. Ltd., and PharmaCore Biotech Co., Ltd.
He is also the General Manager at Excelsior Medical Co., Ltd.
and a Doctor at Dynamic Medical Technologies, Inc. Prior to his current roles, he obtained undergraduate degrees from the University of Ottawa and National Taiwan University College of Medicine.

Posizioni attive di Ming Cheng Chang

Società	Posizione	Inizio
ARICH ENTERPRISE CO., LTD.	Director/Board Member	16/07/2015
EXCELSIOR MEDICAL CO., LTD.	Chief Executive Officer	-
PHARMACORE BIOTECH CO., LTD.	Director/Board Member	28/08/2020
DYNAMIC MEDICAL TECHNOLOGIES INC.	Director/Board Member	-
RTS Excelsior Co. Ltd.	Director/Board Member	-

Tutte le posizioni attive di Ming Cheng Chang

Formazione di Ming Cheng Chang

University of Ottawa	Undergraduate Degree
National Taiwan University College of Medicine	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Ming Cheng Chang

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	3
EXCELSIOR MEDICAL CO., LTD.	Distribution Services
ARICH ENTERPRISE CO., LTD.	Distribution Services
DYNAMIC MEDICAL TECHNOLOGIES INC.	Health Technology

Aziende private	2
RTS Excelsior Co. Ltd.
PharmaCore Biotech Co., Ltd. PharmaCore Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology PharmaCore Biotech Co., Ltd. engages in the development and production of active pharmaceutical ingredients (APIs), including anti-cancer drugs, peptides, and antibiotics. Its business activities include the development and production of private brand products, the provision of customized Contract Research Organisations and Contract Manufacturing Organisations (CRO/CMO) services, and the provision of Pharmaceutical Inspection Co-operation Scheme (PIC/S) and Good Manufacturing Practice (GMP) relative regulatory and submission services. The company was founded on January 8, 2015 and is headquartered in Tainan, Taiwan.	Health Technology